News & Updates

Show Multimedia Only

Novel petrelintide shows promise in obesity treatment

Treatment with a once-weekly injectable petrelintide, a novel human amylin analogue, yields up to 10.7 percent weight loss through week 42 in adults with obesity or overweight, according to the phase II ZUPREME-1 trial presented at ADA 2026.

Novel petrelintide shows promise in obesity treatment

a day ago

Berobenatide a promising addition to the current GLP-1 RA roster

a day ago by

In the phase II VESPER-2 trial, the investigational injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) berobenatide shows robust reductions in weight and HbA1c in adults with obesity/overweight and type 2 diabetes (T2D).

Berobenatide a promising addition to the current GLP-1 RA roster

a day ago

Adjunctive HBOT beneficial for DFUs

23 Jun 2026 by

A meta-analysis presented at ADA 2026 supports the benefits of hyperbaric oxygen therapy (HBOT) for ulcer healing and reducing the risk of major amputation in individuals with diabetic foot ulcers (DFUs).

Adjunctive HBOT beneficial for DFUs

23 Jun 2026

Glucose-lowering therapy tied to reduced risk of depression in T2D

23 Jun 2026

Exposure to several glucose-lowering drugs appears to have a protective effect on the risk of depression in individuals with type 2 diabetes (T2D), according to a population-based cohort study in Hong Kong.

Glucose-lowering therapy tied to reduced risk of depression in T2D

23 Jun 2026

Relative fat mass predicts stroke

22 Jun 2026

Relative fat mass is strongly associated with incident stroke, especially ischaemic stroke, as shown in a study.

Relative fat mass predicts stroke

22 Jun 2026

Testosterone level decline varies in older men

22 Jun 2026

A recent study has noted a broad range of total testosterone levels in older community-dwelling men, with a substantial proportion in a range deemed hypogonadal.

Testosterone level decline varies in older men

22 Jun 2026

Metformin protective against glaucoma

22 Jun 2026 by

A study conducted by researchers from Singapore demonstrates a protective effect of metformin against glaucoma in patients with diabetes.

Metformin protective against glaucoma

22 Jun 2026

OSA linked to thromboembolic event risk among women with PCOS

20 Jun 2026

Women with polycystic ovarian syndrome (PCOS) may have an increased risk of thromboembolic events in the presence of obstructive sleep apnoea (OSA), according to a retrospective study.

OSA linked to thromboembolic event risk among women with PCOS

20 Jun 2026

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

20 Jun 2026

Cardiometabolic comorbidities have shown improvements following surgery in patients with Cushing syndrome (CS) and those with mild autonomous cortisol secretion (MACS), reports a study.

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

20 Jun 2026

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

20 Jun 2026

The use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) among adults with obesity and concomitant autoimmune diseases appears to lower the incidence of thromboembolic events, emergency department visits, and mortality, according to a study.

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

20 Jun 2026

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Novel petrelintide shows promise in obesity treatment

Novel petrelintide shows promise in obesity treatment

Berobenatide a promising addition to the current GLP-1 RA roster

Berobenatide a promising addition to the current GLP-1 RA roster

Adjunctive HBOT beneficial for DFUs

Adjunctive HBOT beneficial for DFUs

Glucose-lowering therapy tied to reduced risk of depression in T2D

Glucose-lowering therapy tied to reduced risk of depression in T2D

Relative fat mass predicts stroke

Relative fat mass predicts stroke

Testosterone level decline varies in older men

Testosterone level decline varies in older men

Metformin protective against glaucoma

Metformin protective against glaucoma

OSA linked to thromboembolic event risk among women with PCOS

OSA linked to thromboembolic event risk among women with PCOS

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

Improved cardiometabolic outcomes seen after surgical remission of endogenous hypercortisolism

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

GLP‐1RA offers cardiovascular, survival benefits in high-risk population